About me

Experience:

2024 -

Present

Honorary Senior Lecturer (Imperial College London, UK)

2024 -

Present

Programme Leader Track (MRC LMS, UK)

2023 -

2024

Senior Research Fellow/ Principal Investigator (University College London, UK)

2015 -

2022

Postdoctoral Research Fellow (MPI-MG, Germany)

2010 -

2014

PhD Molecular Genetics (University of Lorraine, France)

2009 -

2010

Master Science in Bioengineering and Drug Targeting (University of Lorraine, France)

2008 -

2009

Master Science in Biochemistry and Molecular Biology (University of Lorraine, France)

2003 -

2008

Diploma in Pharmacy

Research focus:

Our group aims to understand the molecular consequences of SVs affecting noncoding regions in development and disease. One powerful technique that we plan to use in the lab to answer this question is synthetic genomics. This technique allows us to better understand human pathologies and develop novel therapies by faithfully recapitulating human diseases in mice.

Joined LMS:

2024

About me:

I first got very enthusiastic about understanding the basic mechanisms of genetic diseases when I was an external Pharmacist student in a clinical and medical genetics unit. This fascination has guided my research career to date. Outside the lab, I mostly enjoy going for long walks in London’s charming parks.

Impact of my work:

Our work deepens our understanding of the functional consequences of genetic structural variations affecting noncoding regions. This knowledge could lead to the diagnosis of a substantial portion of the 300 million undiagnosed patients with rare diseases and the development of innovative therapeutic strategies for cancer patients.

My Research

Genomic variation and disease

The genomic variation and disease team at the LMS started in 2024. Led by Lila Allou, it aims to understand the molecular consequences of SVs affecting noncoding regions in development and disease, thereby improving rare disease diagnosis and identifying potential therapeutic targets in cancer.

VIEW MY RESEARCH GROUP